Compare Plby Group Inc (PLBY) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Plby Group Inc vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Plby Group Inc trades at $0.97 (market cap $118.21M), while Royalty Pharma plc Class A Ordinary Shares trades at $56.7 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 213.8× Plby Group Inc's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Plby Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Plby Group Inc for 24 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| PLBY | RPRX | |
|---|---|---|
Market Cap | $118.21M | $25.27B |
Volume | 919,783 | 3,671,183 |
Sector | Consumer Cyclical | Health |
52-Week High | $2.71 | $63.96 |
52-Week Low | $0.99 | $35.44 |
Typical Hold Time | 24 Days | 0 Days |
Enterprise Value | $263.80M | $32.50B |
Dividend Yield | — | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PLBY trades at $1.02, down 1.92% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $12.67 million in 2025, though revenue grew to $120.93 million and the net loss narrowed significantly from prior years. Recent news highlights leadership appointments aimed at driving brand growth. The stock has a high P/E ratio of 49.34 but a reasonable P/S of 0.87, and analyst consensus is strongly bullish with 75% buy ratings.
The outlook is mixed: improving profitability trends and positive analyst sentiment offer potential upside, but high debt levels, negative shareholder equity, and bearish technicals pose significant risks. Investors should weigh the company's growth initiatives against its financial leverage and market volatility.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Plby Group Inc
PLBY Group Inc is a pleasure and leisure company. The company's segment includes Licensing, Direct-to-Consumer, and Digital Subscriptions and Content. It generates maximum revenue from the Direct-to-Consumer segment. Direct-to-Consumer operations include consumer products sold through third-party retailers or online direct-to-customer. Geographically, it derives a majority of revenue from the United States.
Read more on PLBY →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
